Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

Journal of Hepatology

Volumn 62, Issue 1, 2015, Pages 92-100

  Castells, Lluis ^a,b   Rimola, Antoni ^b,c   Manzardo, Christian ^c   Valdivieso, Andrés ^d   Montero, José Luis ^e   Barcena, Rafael ^f   Abradelo, Manuel ^g   Xiol, Xavier ^c   Aguilera, Victoria ^h   Salcedo, Magdalena ⁱ   Rodriguez, Manuel ^j   Bernal, Carmen ^k   Suarez, Francisco ^l   Antela, Antonio ^m   Olivares, Sergio ^g   Del Campo, Santos ^f   Laguno, Montserrat ^c   Fernandez, José R ^d   De La Rosa, Gloria ⁿ   Agüero, Fernando ^c   Perez, Iñaki ^c   González García, Juan ^o   Esteban Mur, Juan I ^a,b   Miro, Jose M ^c   more..

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h HOSPITAL UNIVERSITARIO LA FE   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l HOSPITAL JUAN CANALEJO   (Spain)

^m Instituto de Salud Carlos III   (Spain)

ⁿ ORGANIZACIÓN NACIONAL DE TRASPLANTES   (Spain)

^o HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

more..

Author keywords

Antiviral treatment; HCV infection; HIV infection; Liver transplantation; Pegylated interferon; Recurrence of hepatitis C; Ribavirin; Survival

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFECTIVE AGENT; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; PEGINTERFERON; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TACROLIMUS; ALPHA INTERFERON; ANTIVIRUS AGENT; DRUG CARRIER; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2A; RECOMBINANT PROTEIN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIMICROBIAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; ESOPHAGUS CANDIDIASIS; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 3; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; RECURRENT INFECTION; RESEARCH; RETRANSPLANTATION; SURVIVAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CLINICAL TRIAL; COMBINATION DRUG THERAPY; GENETICS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; MIDDLE AGED; MIXED INFECTION; RECURRENT DISEASE; TREATMENT OUTCOME; VIROLOGY; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; COINFECTION; DRUG CARRIERS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV; HIV INFECTIONS; HUMANS; INTERFERON-ALPHA; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RECURRENCE; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84918585670     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.07.034     Document Type: Article

References (38)

1. Antiretroviral Therapy Cohort Collaboration Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies Lancet 372 2008 293 299
2. E. Martinez, A. Milinkovic, E. Buira, E. de Lazzari, A. Leon, and M. Larrousse Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area HIV Med 8 2007 251 258
3. A.N. Fox, P.A. Vagefi, and P.G. Stock Liver transplantation in HIV patients Semin Liver Dis 32 2012 177 185
4. J.M. Miro, M. Laguno, A. Moreno, and A. Rimola Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol 44 2006 S140 S145
5. M.E. de Vera, I. Dvorchik, K. Tom, B. Eghtesad, N. Thai, and O. Shakil Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C Am J Transplant 6 2006 2983 2993
6. J.C. Duclos-Vallee, C. Feray, M. Sebagh, E. Teicher, A.M. Roque-Afonso, and B. Roche Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus Hepatology 47 2008 407 417
7. N.A. Terrault, M.E. Roland, T. Schiano, L. Dove, M.T. Wong, and F. Poordad Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection Liver Transpl 18 2012 716 726
8. J.M. Miro, M. Montejo, L. Castells, A. Rafecas, S. Moreno, and F. Aguero Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study Am J Transplant 12 2012 1866 1876
9. L. Castells, A. Escartin, I. Bilbao, O. Len, H. Allende, and V. Vargas Liver transplantation in HIV-HCV coinfected patients: a case-control study Transplantation 83 2007 354 358
10. C. Cooper, S. Kanters, M. Klein, P. Chaudhury, P. Marotta, and P. Wong Liver transplant outcomes in HIV-infected patients: a systematic review and meta-Analysis with synthetic cohort AIDS 25 2011 777 786
11. J. Fung, B. Eghtesad, K. Patel-Tom, M. DeVera, H. Chapman, and M. Ragni Liver transplantation in patients with HIV infection Liver Transpl 10 2004 S39 S53
12. G. Vennarecci, G.M. Ettorre, M. Antonini, R. Santoro, L. Perracchio, and G. Visco Liver transplantation in HIV-positive patients Transplant Proc 39 2007 1936 1938
13. K. Wojcik, M. Vogel, E. Voigt, N. Speidel, J.C. Kalff, and G. Goldmann Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort AIDS 21 2007 1363 1365
14. N. Terrault, K.R. Reddy, F. Poordad, M. Curry, T. Schiano, and J. Johl Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients Am J Transplant 14 2014 1129 1135
15. A. Rafecas, G. Rufi, J. Fabregat, and X. Xiol Liver transplantation in a patient infected by human immunodeficiency virus Med Clin (Barc) 119 2002 596
16. J.M. Miro, J. Torre-Cisnero, A. Moreno, M. Tuset, C. Quereda, and M. Laguno GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005) Enferm Infecc Microbiol Clin 23 2005 353 362
17. A.J. Demetris Evolution of hepatitis C virus in liver allografts Liver Transpl 15 2009 S35 S41
18. P. Bedossa, and T. Poynard An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology 24 1996 289 293
19. R.T. Chung, J. Andersen, P. Volberding, G.K. Robbins, T. Liu, and K.E. Sherman Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons N Engl J Med 351 2004 451 459
20. F. Carrat, F. Bani-Sadr, S. Pol, E. Rosenthal, F. Lunel-Fabiani, and A. Benzekri Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial JAMA 292 2004 2839 2848
21. F.J. Torriani, M. Rodriguez-Torres, J.K. Rockstroh, E. Lissen, J. Gonzalez-Garcia, and A. Lazzarin Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients N Engl J Med 351 2004 438 450
22. S.J. Hadziyannis, H. Sette Jr., T.R. Morgan, V. Balan, M. Diago, and P. Marcellin Peginterferon-Alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann Intern Med 140 2004 346 355
23. C.S. Graham, A. Wells, T. Liu, K.E. Sherman, M. Peters, and R.T. Chung Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection AIDS 20 2006 345 351
24. M. Berenguer, A. Palau, A. Fernandez, S. Benlloch, V. Aguilera, and M. Prieto Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C Liver Transpl 12 2006 1067 1076
25. T.M. Antonini, M. Sebagh, A.M. Roque-Afonso, E. Teicher, B. Roche, and R. Sobesky Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation Am J Transplant 11 2011 1686 1695
26. F.D. Gordon, P. Kwo, R. Ghalib, J. Crippin, H.E. Vargas, and K.A. Brown Peginterferon-Alpha-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation J Clin Gastroenterol 46 2012 700 708
27. M. Berenguer Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin J Hepatol 49 2008 274 287
28. R. Rabie, K. Mumtaz, and E.L. Renner Efficacy of antiviral therapy for hepatitis C after liver transplantation with cyclosporine and tacrolimus: a systematic review and meta-Analysis Liver Transpl 19 2013 36 48
29. F.P. Picciotto, G. Tritto, A.G. Lanza, L. Addario, M. De Luca, and G.G. Di Costanzo Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation J Hepatol 46 2007 459 465
30. M. Berenguer, A. Palau, V. Aguilera, J.M. Rayon, F.S. Juan, and M. Prieto Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation Am J Transplant 8 2008 679 687
31. T. Tanaka, N. Selzner, G. Therapondos, E.L. Renner, and L.B. Lilly Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients Transpl Int 26 2013 42 49
32. C.R. Werner, D.P. Egetemeyr, U.M. Lauer, S. Nadalin, A. Konigsrainer, and N.P. Malek Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data Liver Transpl 18 2012 1464 1470
33. A. Coilly, B. Roche, J. Dumortier, V. Leroy, D. Botta-Fridlund, and S. Radenne Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation, a multicenter experience J Hepatol 60 2014 78 86
34. S. Pungpapong, B.A. Aqel, L. Koning, J.L. Murphy, T.M. Henry, and K.L. Ryland Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation Liver Transpl 19 2013 690 700
35. T.M. Antonini, V. Furlan, E. Teicher, S. Haim-Boukobza, M. Sebagh, and A. Coilly Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft AIDS 27 2013 2655 2657
36. D. Samuel, M. Charlton, E. Gane, R.S. Brown Jr., M.P. Curry, and P. Kwo Sofosbuvir and ribavirin for the treatment of recurrent hepatitis C infection after liver transplantation: results of a prospective, multicenter study J Hepatol 60 2014 S499
37. M.S. Sulkowski, S. Naggie, J. Lalezari, W.J. Fessel, K. Mounzer, and M. Shuhart Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection JAMA 312 2014 353 10.1001/jama.2014.7734
38. E. Lawitz, A. Mangia, D. Wyles, M. Rodriguez-Torres, T. Hassanein, and S.C. Gordon Sofosbuvir for previously untreated chronic hepatitis C infection N Engl J Med 368 2013 1878 1887